CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic `window of opportunity'

Title
CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic `window of opportunity'
Authors
Keywords
Rheumatoid Arthritis, Adalimumab, Early Rheumatoid Arthritis, Simplify Disease Activity Index, CXCL13 Level
Journal
ARTHRITIS RESEARCH & THERAPY
Volume 16, Issue 5, Pages -
Publisher
Springer Nature
Online
2014-09-24
DOI
10.1186/s13075-014-0434-z

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now